多巴胺和血清的共传过器通过5-HT1B受体激活来过排列性突触活性
Maya Molinari1, Alina Aaltonen1, Ori J Lieberman2
1Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Science advances
|November 5, 2025
概括
多巴胺抑制了大脑中的GABA释放.
科学领域:
- 神经科学是一个神经科学.
- 神经生物学 神经生物学 神经生物学
- 细胞神经科学 细胞神经科学
背景情况:
- 黑色物质网状体 (SNr) 是一个关键的基底细胞输出核.
- 人们认为多巴胺 (DA) 通过中脑神经元的局部释放来调节SNR活动.
- 通过DA调节GABA从中等脊髓神经元 (MSN) 终端释放GABA的精确机制尚未完全理解.
研究的目的:
- 研究多巴胺对从MSN终端释放GABA的调节背后的机制.
- 澄清多巴胺受体和其他神经递质系统在这个过程中的作用.
- 阐明这些通路对基底腺功能和神经系统疾病的贡献.
主要方法:
- 在D1-MSN突触中,突触囊融合和流入的突触前光学记录.
- 来自SNR神经元的 postsynaptic补丁记录.
- 在脑切片和体内纤维光度学中采用双光子血清激素生物传感器成像.
主要成果:
- 发现多巴胺可以以频率依赖的方式抑制D1-MSN的GABA释放.
- 这种抑制作用独立于多巴胺受体,但需要激活5-HT1B受体.
- 多巴胺被证明可以通过抑制血清素再吸收来增加SNR中的细胞外血清素水平.
结论:
- 血清激素,而不是多巴胺受体,调解多巴胺对基底腺节输出的控制.
- 这种血清素介导的途径与多巴胺类药物治疗帕金森病和精神兴奋剂相关疾病的治疗作用有关.
- 这些发现揭示了在基底腺回路中神经递质相互作用的新机制.
相关概念视频
Neurochemical Transmission: Sites of Drug Action
3.4K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.4K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
867
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
867
G-protein Coupled Receptors
131.4K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.4K
Cholinergic Neurons: Neurotransmission
5.0K
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
5.0K


